Asymmetric Intrauterine Growth Restriction Causes and Characteristics
Etiology and Pathophysiology
- The American College of Obstetricians and Gynecologists notes that placental insufficiency is the most common cause of asymmetric IUGR, accounting for 25-30% of all fetal growth restriction cases 1
- Placental insufficiency due to suboptimal perfusion of the maternal-placental circulation is the leading cause, responsible for 25-30% of all FGR cases 1
- The American Journal of Obstetrics and Gynecology reports that chromosomal disorders and congenital malformations account for approximately 20% of FGR cases 1
Clinical Presentation and Diagnosis
- The American College of Radiology suggests that earlier in gestation, chromosomal anomalies, syndromes, and viral infections are more common etiologies 2, 3
- Later in gestation, placental insufficiency predominates, especially related to hypertension and maternal vascular disease 2, 3
- Asymmetric FGR with "head-sparing" is characteristically more common in late-onset cases, where placental insufficiency leads to preferential blood flow redistribution to protect the fetal brain at the expense of abdominal/somatic growth 2, 3
Evaluation and Management
- The American College of Obstetricians and Gynecologists recommends that maternal history of hypertensive disorders is a key association with late-onset asymmetric FGR 4, 5
- A detailed fetal structural survey should have been performed prenatally, as approximately 10% of fetuses with FGR have congenital anomalies 2
Fetal Abnormalities Contributing to Intrauterine Growth Restriction (IUGR)
Epidemiology
- Chromosomal disorders and congenital malformations together account for ≈ 20 % of all IUGR cases, making them the second‑most common cause after placental insufficiency. 6
Diagnostic Testing
Early‑Onset IUGR (< 32 weeks)
- Chromosomal microarray analysis (CMA) is recommended for unexplained isolated IUGR diagnosed before 32 weeks (GRADE 1C). This test provides a 4–10 % incremental diagnostic yield over standard karyotyping. 6
- When amniocentesis is performed for unexplained IUGR, polymerase chain reaction (PCR) testing for cytomegalovirus (CMV) should be offered. 6
Infectious Screening
- Do not screen for toxoplasmosis, rubella, or herpes in the absence of specific risk factors, as routine testing adds no clinical benefit. 6
Management & Surveillance
- After an IUGR diagnosis, serial umbilical artery Doppler assessments should be performed to monitor for fetal deterioration. 6
Resource Utilization
- Ordering unnecessary infectious disease screening (toxoplasmosis, rubella, herpes) without risk factors wastes resources and may delay appropriate management. 6